Adding ACEI to Chemotherapy Does Not Prevent Cardiotoxicity
The addition of an angiotensin-converting enzyme (ACE) inhibitor did not decrease risk for chemotherapy-related cardiac damage in patients being treated for breast cancer and non-Hodgkin lymphoma (NHL), a new randomized trial showed. The results suggested …